Skip to content
Win World Magazine

The Zimbabwean Government Declines ‘One-Sided’ US Healthcare Assistance Deal Because of Information Fears

Health funding image
The offered American financial assistance would have supported programmes for treating and preventing HIV/Aids, TB, and malarial diseases.

The nation of Zimbabwe has turned down a significant US health deal worth 367 million US dollars (272 million pounds) over five years due to Washington's demand for sensitive biological samples.

This rejection came to light following a government memo from December was disclosed, indicating that President Emmerson Mnangagwa believed the deal was "unbalanced".

An official spokesperson later clarified that the United States was demanding access to biological samples for scientific study and commercial gain but was unwilling to share the benefits from any future treatments.

"We will now turn to the challenging and unfortunate process of scaling back our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.

Her embassy said the United States had provided more than $1.9bn as health assistance to Zimbabwe during the past two decades.

A physicians' group in Zimbabwe has urged continued dialogue to secure a deal agreeable to all parties so the nation's critical HIV programme can continue.

Wider Context

Zimbabwe's decision comes after a similar situation in neighbouring Kenya, where a court halted a related deal with the US following concerns were filed about the security of Kenyans' medical information.

After resuming office last year, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).

USAID had overseen aid for the US government, but Trump claimed its spending was "wasteful" and his administration was pursuing direct bilateral deals to boost openness and accountability.

Based on reports, Sixteen nations in Africa have so far signed these new agreements, representing over $18.3bn in committed funds.

Specifics of the Rejected Deal

The funds for Zimbabwe would have funded "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.

"We believe this collaboration might have yielded immense benefits for Zimbabwean communities, particularly the 1.2 million men, women and children currently on HIV treatment via US-supported initiatives," the Ambassador added.

However, government spokesperson Nick Mangwana maintained the proposed deal was "unequal".

"Our nation was requested to surrender its genetic material and health information indefinitely, without any corresponding promise of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might be developed from that shared data," he stated.

"Effectively, our country would supply the basic resources for scientific discovery with no certainty that the resulting innovations would be available to our citizens if a future pandemic arise."

National Interest and International Frameworks

He also pointed out that the American exit from the World Health Organization (WHO) and its pursuit of bilateral health agreements were disrupting structures already established via the global health agency.

The spokesperson gave as an example its Pathogen Access and Benefit Sharing framework designed to deal with potential pandemics.

"This mechanism is intended to ensure that when a country provides its data, the resulting advantages – such as medicines and cures – are shared equitably, not commercialised exclusively by those with the capability to create them."

These objections regarding the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.

"We are open to continued dialogue with our American counterparts on how future collaboration could be structured in a manner that honours the sovereignty and interests of each country."

Health Experts Response

The Zimbabwe College of Public Health Physicians (ZCPHP) said it acknowledged the government's concerns, but urged that negotiations must proceed considering a large portion of the nation's Aids initiatives relied on external financing.

"If specific concerns exist, including those involving information security or agreement terms, these can frequently be addressed via detailed discussion and mutually agreed protections," it commented.

The halted deal highlights the continuing debate between receiving vital international aid and safeguarding local interests in an increasingly data-driven world.

By

Adam Gallagher

A tech journalist with a passion for gaming and consumer electronics, covering UK tech trends for over a decade.

Win World Magazine

Type to search articles.